Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term oral fosravuconazole for tinea pedis
jRCTs031220578Completed
- Sponsor
- Sato Pharmaceutical
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fosravuconazole in Athlete's foot (2 arms), sponsored by Sato Pharmaceutical. Primary endpoints: Primary endpoint – clinical response (interdigital/vesicular type) and Primary endpoint – clinical response (keratotic type). Started Feb 2023; status: completed.
02
Drugs
fosravuconazole
03
Conditions
Athlete's foot
Beyond the preview
Go deeper on jRCTs031220578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220578.